Parent-FORT: Fear of Cancer Recurrence therapy for parents of childhood cancer survivors
Official title: Addressing Fear of Cancer Recurrence in Parents of Pediatric Cancer Survivors: Adapting The Fear Of Recurrence Therapy (FORT) for Parents and Establishing Acceptability and Feasibility
Run by University of Ottawa · NCT06872840 · Data updated 2026-11-12
This pilot tests a virtual group therapy called Parent-FORT to see if it reduces fear of cancer recurrence and improves quality of life for parents of childhood cancer survivors.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 36 (estimated) |
| Sponsor | University of Ottawa Academic / other |
| Locations | 1 site (Ottawa, Ontario) |
| Status | Recruiting |
| Started | August 26, 2025 |
| Main results expected | August 26, 2026 |
| Study ends | May 26, 2027 |
| Registry record updated | September 22, 2025 |
| Trial ID | NCT06872840 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are English-speaking parents or primary caregivers living in Canada of a child under 18 who completed cancer treatment at least one month ago, who have clinical FCR (FCRI-SF-P ≥13) and internet access.
✕Probably not a fit
Parents who are non-English speakers, whose child is now an adult (≥18), whose child has active unstable graft-versus-host disease after transplant, who have unmanaged serious mental health conditions, or who are already in a therapist-led psychosocial group are unlikely to benefit or be eligible.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot will recruit 36 parents in Canada to participate in four videoconference groups (two intervention groups and two waitlist-control groups) led by three experienced therapists. Eligible parents must score ≥13 on the FCRI-SF-P, have internet access, and be at least one month post their child's completion of active treatment. The study will measure feasibility and acceptability (recruitment, attendance, participation, and parent satisfaction) and collect preliminary clinical outcomes on fear of recurrence and quality of life. Predefined recruitment thresholds over a 15-month period will guide decisions about feasibility for a larger multicenter randomized trial.
Why it matters
Potential benefit: If successful, Parent-FORT could reduce parents' fear of cancer recurrence and improve their quality of life using a brief virtual group format.
How similar studies have gone: Similar brief FCR interventions and group therapies have shown benefit for adult cancer survivors, but Parent-FORT is novel because these approaches have not been tested specifically with parents of childhood cancer survivors.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Parent (or primary caregiver) caring for a childhood cancer survivor (\<18 years of age) of any type of cancer type, who is at least 1 months from the completion of active treatment and has not had a recurrence of their cancer * A score of 13 or greater on the Fear of Cancer Recurrence Inventory-Short Form-Parent version (FCRI-SF-P; range 0-36), suggesting clinical levels of FCR * Access to a computer and internet connection * Living in Canada Exclusion Criteria: * Being the parent of a pediatric cancer survivor who is now 18 years of age or older * Being the parent of a pediatric cancer survivor who has undergone hematopoietic cell transplantation and has active chronic or acute graft-versus-host disease which has not stabilized for at least 3 months * Non-English speakers * Currently participating in another therapist-led psychosocial therapy group * Parent with unmanaged/undermanaged mental health disorder judged to be clinically contraindicated and/or likely to affect the group work * To avoid violating the assumption of nonindependence of the data, only one parent/caregiver per child can participate in the study.
Where it's running
-
University of Ottawa
Ottawa, Ontario, Canada Recruiting
Study contacts
- Principal investigator: Sophie Lebel, PhD — University of Ottawa
- Study coordinator: Celeste Holy, B.A
- Email: choly@uottawa.ca
- Phone: 6135625800
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Think-Find-Solve activities for insulin self-management in children with type 1 diabetes
A behavior-change activity book is tested with children aged 8–12 with type 1 diabetes and their parents to see if it improves daily insulin self-management.
-
SchoolCare uses telepresence robots, school navigation, and teleteaching to keep children with cancer connected to school.
This program will test whether telepresence robots combined with school navigation and teleteaching help children aged 5–17 undergoing cancer treatment stay linked to school and improve attendance, learning, and social well-being.
-
Mind-body therapies to help anxiety in young cancer survivors
This study tests whether hypnosis and relaxation, added to usual care, can reduce anxiety in children, teens, and young adults who have survived cancer.
-
Patient-partnered look at fear of cancer returning after kidney cancer surgery
This project will work with people who had kidney cancer surgery and their partners to see if patient-led questions, timing, and digital methods can better identify fear that the cancer will come back.
-
ECCCLORE group program for people with addiction and trauma-related PTSD
This program will try a group-based ECCCLORE therapy to see if it helps people who have addiction and PTSD or complex PTSD reduce substance use and impulsive or hostile behaviors.
-
Pain and sleep problems in children who survived cancer
This study tests how pain and sleep disturbances relate in children who survived cancer compared with healthy peers.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.